Imprimis inks licence agreement with Urigen for patented ...
pharmabiz.com › News
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, October 31, 2014
Imprimis inks licence agreement with Urigen for patented compound formulation
Notice from Texas Board of Pharmacy Regarding New Rules
Rules adopted at the August 2014 Board meeting were published as adopted in the September 5, 2014, issue of the Texas Register and became effective September 11, 2014. Rules proposed at the February Board meeting were posted in the September 26, 2014, issues of the TexasRegister. The proposed rules will be considered for adoption at the next TSBP board meeting on November 4, 2014. You may view a summary of the adopted and proposed rules here. Please note underlined language is new language and language that is being deleted is lined out. All other language is currently in the rules and is not being changed.
Charter underwrote bought peptides were not for human use: Another discussion feed to read
Charter underwrote bought peptides were not for human use | Page 7 ...
www.bigfooty.com › ... › Hot Topic - The AFL, ASADA and Drugs10 hours ago - 25 posts - 16 authorsDiscussion in 'Hot Topic - The AFL, ASADA and Drugs' started by Ancient Tiger, ... the TB4 which Alavi had compounded, and lo and behold, what do you know?
Read this Discussion Regarding Compounded Pain Cream GPI-107-See picture of the compounded drug label ( 6 refills)
$1100 prescription pain reliever - AR15.COM
13 hours ago - 51 posts - 41 authors... think that is bad. Some of the compound meds are fucking insane. ...
Thursday, October 30, 2014
Nevada Division of Insurance accepting Comments until 11/5/2014 regarding amendments to the prescription drug formularies
NEVADA
The Division of Insurance will accept comments until 11/5/2014 regarding amendments to the prescription drug formularies. The proposed amendments will prohibit certain health insurers that provide coverage for prescription drugs and use a drug formulary from making certain changes to the formulary after its approval by the Commissioner of Insurance.Carter Alleman at ca@stateside.com
source found here
Louisana Board of Pharmacy Held a Public Hearing today 10/30/2014 to Discuss Rule Amendments to Compounded Medications
LOUISIANA
The Board of Pharmacy will hold a public hearing 10/30/2014 to discuss rule amendments to the compounding of medications. David Owens atdo@stateside.com
California Board of Pharmacy to hold public hearing 11/4/2014 to discuss proposed amendments to he compounding rules
CALIFORNIA
The Board of Pharmacy will hold a public hearing 11/4/2014 to discuss proposed amendments to the Compounding Rule. Melissa Martin atmpf@stateside.com
Forbes: Why Do We Care About Doctor Self Referrals?
Let’s say a doctor refers a patient for an MRI scan to a clinic he has a financial interest in. Or sends a patient for a series of tests to a lab he owns. Should we care about any of this? We probably wouldn’t if patients paid for their own care with their own money. But when insurance pays the bills, the medical marketplace becomes like an arms race – with providers and payers constantly battling over what will be covered and will be paid.
Observation of the Day October 30, 2014 There appear to be very few salaried marketing or sales representatives and a lot of commission 1099 based sales representatives in the compounding industtry
Even ICAP has cautioned that this is an area that "{t}his is a particularly complicated issue but what every compounder who currently or is considering employing a contract sales person needs to know is that you, the employer, are directly accountable for the actions, statements and behavior of your sales person. more from IACP found here
Insurer had duty to defend against defamation claims Health plan’s comments about compounded drugs covered under its policy
By: Eric T. Berkman October 30, 2014
A liability insurer had a duty to defend a health plan against a defamation suit brought by compounding pharmacies in connection with statements the plan made when it decided to stop covering “compounded medications,” a Superior Court judge has found. The defendant insurer maintained that the plaintiff health plan’s decision to stop covering compounded drugs breached ...
Read more: http://masslawyersweekly.com/2014/10/30/insurer-had-duty-to-defend-against-defamation-claims/#ixzz3Hecpteeg
Alliance of Independent Pharmacists of Texas Reports on Current Contributors to the RX Pac: How many of these are compounding pharmacists?
Current Contributors Include:
Chris Alvarado, Oakdell Pharmacy
Steve Balas, Eagle Lake Drugstore
Nario Cantu, Cantu's Pharmacy
John Jeff Carson, Sr., Oakdell Pharmacy
John Jeff Carson, Jr., Oakdell Pharmacy
Royce G. "R.G."Cook Jr., Kerrville Drug Company
Dee Ann Downing, Med Shop Total Care Pharmacy
Pat & Jan Downing, Med Shop Total Care Pharmacy
John Dyer, MD Pharmacy
Robert Floyd, Hance Scarborough
Benjamin Fry, Frys Prescription Pharmacy
Maureen Gallagher, Gallagher's Pharmacy
Harmison, Harmison Pharmacies
Chuck Hopson
Ed Horton, Tanglewood Pharmacy
Gil & Audrey Johnson
Travis Leeah, Unique Pharmaceuticals
Georgia Leech, Community Care Pharmacy
Bruce McAnally, Bonham Family Drug
Ann & Joey Maxwell, Maxwell Pharmacy
Artie Mitchell, Medicine Shoppe
William "Bill" Noble, Noble Strategic
Larry Oliver, Sonterra RX
Mark Peippo, Family Pharmacy of Pottsboro
David Spence, Medicine Shoppe
William "Bill" Swail, People's Pharmacy
Anjanette Wyatt, Clinical Care Pharmacy
Wilson Taylor, Dyer Drug Store
Jenny Yoakum, Med Shop Total Care Pharmacy
quoted from here
Chris Alvarado, Oakdell Pharmacy
Steve Balas, Eagle Lake Drugstore
Nario Cantu, Cantu's Pharmacy
John Jeff Carson, Sr., Oakdell Pharmacy
John Jeff Carson, Jr., Oakdell Pharmacy
Royce G. "R.G."Cook Jr., Kerrville Drug Company
Dee Ann Downing, Med Shop Total Care Pharmacy
Pat & Jan Downing, Med Shop Total Care Pharmacy
John Dyer, MD Pharmacy
Robert Floyd, Hance Scarborough
Benjamin Fry, Frys Prescription Pharmacy
Maureen Gallagher, Gallagher's Pharmacy
Harmison, Harmison Pharmacies
Chuck Hopson
Ed Horton, Tanglewood Pharmacy
Gil & Audrey Johnson
Travis Leeah, Unique Pharmaceuticals
Georgia Leech, Community Care Pharmacy
Bruce McAnally, Bonham Family Drug
Ann & Joey Maxwell, Maxwell Pharmacy
Artie Mitchell, Medicine Shoppe
William "Bill" Noble, Noble Strategic
Larry Oliver, Sonterra RX
Mark Peippo, Family Pharmacy of Pottsboro
David Spence, Medicine Shoppe
William "Bill" Swail, People's Pharmacy
Anjanette Wyatt, Clinical Care Pharmacy
Wilson Taylor, Dyer Drug Store
Jenny Yoakum, Med Shop Total Care Pharmacy
quoted from here
Over 1.5 Million kids admit using anabolic steroids: Taylor Hooton Foundation
Taylor Hooton Foundation website post stories relating to steroids
Here is an example of the stories it features:
An 18-year-old man from Australind has pleaded guilty to 14 charges of drug possession after Bunbury police made a major seizure of steroids last month. more
the website is found at http://taylorhooton.org/tag/anabolic-steroids/
Question of the Day October 30, 2014 While high-quality testing is important in horse racing, isn't there another aspect that is just if not more important? Isn't it essential to have investigators and people involved with expert knowledge of the questions to ask, what drugs are illegal and legal, and methods used to avoid detection during testing?
Horse trainer found guilty of fraud in doping case:Derek Riesberry is the first person in Canada to go before the criminal courts for horse doping.
http://blogs.windsorstar.com/news/horse-trainer-found-guilty-of-fraud-in-doping-case
Needle-Free Drug Delivery Devices Market (Jet Injectors, Inhalers, Transdermal Patch and Novel Needle Technology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
LONDON, Oct. 29, 2014 /PRNewswire/ -- Needle-free drug delivery devices are novel techniques to introduce drugs into patient's body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. This report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications. Needle-free drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these devices has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for development of home-care and self medication devices and others. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
continue here
continue here
Compounding Practices and Their Impact on Product Quality
BY MARGARET SPEED RICCI AND HANNS-CHRISTIAN MAHLER
Protein biopharmaceuticals are frequently prepared aseptically in a hospital pharmacy or manufactured in advance in a compounding facility or center, and the ready-to-administer preparations are likely subjected to a holding time before use. Aseptic preparation (or “traditional” compounding) of ready-to-administer parenteral preparations by dilution, reconstitution, or infusion preparation can be done for individual patients within a hospital pharmacy, whereas bulk production (or “nontraditional” compounding) of ready-to-administer preparations at compounding centers is considered manufacturing. Because of the scale of production and potentially significant holding times of the compounded products, general good practice (GxP) manufacturing considerations should be required.
Acology, Inc. and Specialty Pharmacy, a Dispensing Chemists Compounding Pharmacy, Announce Agreement to Provide the Medtainer to Customers
Acology, Inc. (OTCQB: ACOL), maker of the first-ever polypropylene (PP) airtight, watertight, smell-proof medical grade container, announced today that they have closed an agreement to provide its signature product, The Medtainer™ to Specialty Pharmacy, a dispensing chemists compounding pharmacy located in Corona, CA.
Citing the specialized nature of compounding pharmacies and commenting upon the most singular feature of The Medtainer, Diane Ahn, Pharm D. RPh., stated, "We found the Medtainer extremely effective in reducing pills, and especially hard pills, to a fine powder in just a matter of seconds. This reduced the need to use more traditional methods, such as a mortar and pestle, saving us time and energy."
continue to read here
Wednesday, October 29, 2014
Imprimis Pharmaceuticals Enters into License Agreement
Imprimis Pharmaceuticals Enters into License Agreement for ...
www.wcax.com/.../imprimis-pharmaceuticals-enters-into-licens...WCAX‑TV
Subscribe to:
Posts (Atom)